Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Hulin Jin"'
Publikováno v:
IEEE Access, Vol 12, Pp 125993-126005 (2024)
A meme is social media content with which the creator tries to convey a certain idea in public via the internet. Each meme consists of typically an image and supporting text. Its message can be humorous and inspiring, but hilarious and offensive ofte
Externí odkaz:
https://doaj.org/article/a2734a3f104549fdb929041b73894119
Publikováno v:
Case Studies in Thermal Engineering, Vol 51, Iss , Pp 103622- (2023)
This research was done to build computational models for estimating solubility of hydrogen (S) in a given system based on the inputs of temperature (T) and pressure (P). In fact, multiples models were built considering double inputs and single output
Externí odkaz:
https://doaj.org/article/3a20d5624ba148448b490e92fdd52097
Publikováno v:
Energy Reports, Vol 8, Iss , Pp 13979-13996 (2022)
Since fossil fuels are slowly depleting, bio and renewable energies are now given more attention. The main purpose of this research is to investigate and optimize the influencing parameters of bioenergy production through transesterification process.
Externí odkaz:
https://doaj.org/article/8fea123970fa4d738c546d602fccb520
Autor:
Hulin Jin, Vittorio D'Urso, Berend Neuteboom, Sean D. McKenna, Rene Schweickhardt, Alec W. Gross, Yves Fomekong Nanfack, Andrea Paoletti, Carina Carter, Lars Toleikis, Markus Fluck, Juergen Scheuenpflug, Ti Cai
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Avelumab is an IgG1 anti–programmed death ligand 1 (anti–PD-L1) monoclonal antibody that has been approved as a monotherapy for metastatic Merkel cell carcinoma and advanced urothelial carcinoma, and in combination with axitinib for advanced rena
Externí odkaz:
https://doaj.org/article/ed0c00235af4481796eef009cb21a55f
Publikováno v:
Ceramics International. 48:33949-33956
Autor:
Jonathan, Barratt, James, Tumlin, Yusuke, Suzuki, Amy, Kao, Aida, Aydemir, Kishore, Pudota, Hulin, Jin, Hans, Gühring, Gerald, Appel
Publikováno v:
Kidney International Reports. 7:1831-1841
Patients with IgA nephropathy (IgAN) and persistent proteinuria are at risk of progression to kidney failure. Atacicept is a novel B-cell-targeted immunomodulator, shown to reduce immunoglobulin levels in patients with autoimmune diseases.JANUS (NCT0
Autor:
Heinz Wiendl, Nicola De Stefano, Frederik Barkhof, Xavier Montalban, Anat Achiron, Tobias Derfuss, Andrew Chan, Suzanne Hodgkinson, Alexandre Prat, Letizia Leocani, Klaus Schmierer, Finn Sellebjerg, Patrick Vermersch, Hulin Jin, Elina Jarvinen, Anita Chudecka, Lidia Gardner
Publikováno v:
Monday, April 24.
Autor:
Saiama N. Waqar, Clifford Robinson, Anthony J. Olszanski, Alexander Spira, Melissa Hackmaster, Luisa Lucas, Laura Sponton, Hulin Jin, Ursula Hering, Damien Cronier, Marianna Grinberg, Annick Seithel-Keuth, Ivan Diaz-Padilla, Jordan Berlin
Publikováno v:
Investigational New Drugs. 40:596-605
SummaryBackground. Ataxia telangiectasia mutated (ATM) kinase orchestrates DNA double strand break (DSB) repair; ATM inhibitors may therefore enhance the therapeutic effect of DSB-inducing treatments such as radiotherapy (RT). M3541 is an orally admi
Autor:
Zheng Feng, Michael Schlichting, Christoph Helwig, Everett E. Vokes, Mary Ruisi, Juergen Scheuenpflug, Zhen Su, Keith M. Kerr, Martin Reck, Hulin Jin, Claudia-Nanette Gann, Hans Juergen Grote
Publikováno v:
Journal of Thoracic Oncology. 15:1306-1316
Introduction Several programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) assays have been developed independently within clinical programs for therapeutic anti–programmed cell death protein 1 (anti–PD-1) or PD-L1 antibodies, necessitatin
Autor:
Berend Neuteboom, Juergen Scheuenpflug, Yves Fomekong Nanfack, Hulin Jin, Rene Schweickhardt, Mckenna Sean D, Carina Carter, Alec W. Gross, Vittorio D'Urso, Andrea Paoletti, Lars Toleikis, Markus Fluck, Ti Cai
Publikováno v:
Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 10, Iss 1 (2021)
article-version (VoR) Version of Record
OncoImmunology, Vol 10, Iss 1 (2021)
Avelumab is an IgG1 anti–programmed death ligand 1 (anti–PD-L1) monoclonal antibody that has been approved as a monotherapy for metastatic Merkel cell carcinoma and advanced urothelial carcinoma, and in combination with axitinib for advanced rena